WMG Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Sell
1,076
-62
-5% -$13.3K 0.1% 78
2026
Q1
$248K Sell
1,138
-14
-1% -$3.11K 0.1% 81
2025
Q4
$263K Sell
1,152
-543
-32% -$124K 0.11% 86
2025
Q3
$392K Sell
1,695
-43
-2% -$8.76K 0.13% 107
2025
Q2
$323K Buy
1,738
+48
+3% +$8.92K 0.12% 118
2025
Q1
$354K Sell
1,690
-447
-21% -$86.9K 0.15% 95
2024
Q4
$380K Buy
2,137
+93
+5% +$17.1K 0.16% 90
2024
Q3
$404K Buy
2,044
+7
+0.3% +$1.31K 0.18% 78
2024
Q2
$349K Buy
2,037
+427
+27% +$70.7K 0.18% 81
2024
Q1
$293K Buy
1,610
+148
+10% +$25.5K 0.17% 95
2023
Q4
$227K Sell
1,462
-400
-21% -$58.3K 0.15% 105
2023
Q3
$278K Buy
1,862
+63
+4% +$9.25K 0.24% 73
2023
Q2
$242K Buy
1,799
+215
+14% +$31.5K 0.18% 94
2023
Q1
$295K Sell
1,584
-1,680
-51% -$257K 0.24% 71
2022
Q4
$527K Buy
3,264
+21
+0.6% +$3.22K 0.45% 59
2022
Q3
$438K Buy
3,243
+129
+4% +$18.5K 0.39% 67
2022
Q2
$478K Sell
3,114
-193
-6% -$29.5K 0.41% 61
2022
Q1
$537K Buy
3,307
+69
+2% +$10K 0.39% 63
2021
Q4
$438K Buy
+3,238
New +$382K 0.34% 75

Other funds holding ABBV

WMG Financial Advisors's ABBV Position: Q2 2026 in Review

WMG Financial Advisors reduced its AbbVie (ABBV) stake by 5.4% in Q2 2026, selling an estimated $13.3K and leaving 1,076 shares worth $271K. The position accounts for 0.1% of the portfolio, ranked #78.

WMG Financial Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $537K in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WMG Financial Advisors held 1,076 shares of AbbVie worth $271K as of Q2 2026.
  • WMG Financial Advisors sold 62 AbbVie shares in Q2 2026, an estimated $13.3K.
  • AbbVie made up 0.1% of WMG Financial Advisors's portfolio in Q2 2026, its #78 holding.
  • WMG Financial Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • WMG Financial Advisors's AbbVie position peaked at $537K in Q1 2022.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WMG Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.